Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment

Journal of Clinical Investigation

Volumn 107, Issue 4, 2001, Pages 505-517

  Malhotra, U ^a   Holte, S ^a   Dutta, S ^a   Berrey, M M ^a   Delpit, E ^a   Koelle, D M ^a   Sette, A ^a   Corey, L ^a   McElrath, M J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035113972     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11275     Document Type: Article

References (54)

1. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
2. Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome
3. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome
4. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men: HIV affects the immune system before CD4+ T cell depletion occurs
5. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
6. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection
7. Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection
8. Host factors in the pathogenesis of HIV disease
9. Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men
10. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study
11. Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: Association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS
12. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
13. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
14. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
15. CCR5 promoter polymorphism and HIV-1 disease progression
16. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma
17. Clinical and epidemiologic features of primary HIV infection
18. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
19. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
20. Self peptide requirement for class II major histocompatibility complex allorecognition
21. Several common HLA-DR types share largely overlapping peptide binding repertoires
22. The measurement of MHC/peptide interactions by gel infiltration
23. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules
24. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: A model for unidirectional alloimmune responses
25. Semiparametric models for longitudinal data with application to CD4 cell numbers in HIV seroconverters
26. Performance of generalized estimating equations in practical situations
27. Relative HLA-DRB1*13 allele frequencies and DRB3 associations of untelated individuals from five US populations
28. Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitation
29. Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy
30. Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52
31. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain
32. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
33. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
34. Ongoing HIV dissemination during HAART
35. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
36. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
37. An essential role for type 1 interferon-gamma in terminating persistent viral infection
38. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype
39. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo
40. MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo
41. Peptide analogs with different affinites for MHC alter the cytokine profile of T helper cells
42. Sequencing-based typing reveals new insight in HLA-DPA1 polymorphism
43. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease
44. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection
45. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons
46. T cell recognition of HIV synthetic peptides in a natural infection
47. T-cell response to HIV in natural infection: Optimized culture conditions for detecting responses to gag peptides
48. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes
49. Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells
50. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein
51. Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types
52. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
53. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
54. Common west African HLA antigens are associated with protection from severe malaria